Assay

Financial-condition grades for SEC filers

Company Report · as of Oct 9, 2026


HomeCompaniesSectorsCalendarLast night

Sera Prognostics, Inc.SERA · healthcare
GradeNonecomputable_factors_below_threshold: 6 of 14 inputs computable; 7 are required
Reliability0.83 AUCfailure model, filers with $12.5M to $120M assets; 95% interval 0.79 to 0.86; 201 events, 2020 to 2025
Peer failure rate1.07% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025
Size band$12.5M to $120M assetstotal assets $101.9M[1]
Standard universeoutsiderevenue above $1M and assets above $10M[1-2]
Warningsshort runway, thin data, degenerate inputsnot computable: dilution, distress, fortress balance sheet
Inputs computable6 of 14
Graded fromfilings received through Mar 18, 2026205 days before the rescan; every figure keyed to the SEC receipt date
Last close$2.022026-10-05; market equity $59.3M; iex feed
Price used in gradeNone
Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history
$2$3NovDecJanFebMarAprMayJunJulAugSepOct$2.02
ABCDE20132014201520162017201820192020202120222023202420252026

Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date.

Open this report as it stood on

Letter setLetterPercentileBand
Jan 21, 2012nonen/a
Apr 21, 2022nonen/aQ3
Apr 21, 2023nonen/aQ2

Each date opens the report as it stood on that rescan.

Business, in the company's words. Opening of Item 1 of the 10-K received Mar 18, 2026; the document on sec.gov.

We are a women’s health company utilizing our proprietary proteomics and bioinformatics platform, and significant data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. Our vision is to become the global leader in high-value women’s health diagnostics. We plan to do this by taking a holistic approach to providing pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother’s pregnancy journey, improve maternal and neonatal health, and reduce health care costs.

Warnings [top]

Short runway. cash runway is 1.9 months[3]
Thin data. 6 of 14 grade factors are computable; minimum is 7
Degenerate inputs. latest revenue or assets are at or below the $100,000 validity floor[1-2]

7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.

The Fourteen Inputs [top]

Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.

InputPercentile, 0 to 100ValueSourcePeer medianPercentilePeersPeriod end
Profitability, sleeve percentile 75.1
Gross profitability(0.08%)[1-2,4]32.2%97.03722025-12-31
Return on invested capitalnot computable9.3%
one or more required annual facts are missing
Accruals ratio(7.2%)[1,5-7](6.6%)53.18112025-12-31
Gross margin stability, five yearsnot computable2.8 pts
five annual gross margins are required; found 2
Solvency, sleeve percentile 68.0
Twelve-month failure probabilitynot computable0.07%
liabilities and a nearby cover-page share count are required at 2026-06-30
Altman Z double-prime(8.32)[1,8-13](0.31)59.17562025-12-31
Net debt to EBITDAnot computable1.82x
one or more required annual facts are missing
Interest coveragenot computable(4.51x)
interest expense must exceed $100,000
Current ratio1.69x[8-9]2.96x76.88392025-12-31
Growth and financing, sleeve percentile 76.9
Revenue growth, three-year compound(32.9%)[2,14-16]10.0%92.34152025-12-31
Free cash flow growth, three-year compoundnot computable10.9%
current FCF must be positive and base FCF must exceed $100,000
Reinvestment ratenot computable37.1%
NOPAT must exceed $100,000
Asset growth, three years(4.3%)[1,7,17-18]2.1%61.57042025-12-31
Net share issuance, one yearnot computable2.5%
two annual share counts are required; found 0

Gross profitability. Revenue less cost of goods sold, over total assets.

Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.

Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.

Twelve-month failure probability. CHS model; lower is stronger.

Net debt to EBITDA. Lower is stronger.

Net share issuance, one year. Split-adjusted; lower is stronger.

Among 371 Peers [top]

What the Price Implies [top]

Market measures at the 2026-10-05 close. None enters the grade. Percentile among graded peers with the same measure.

MeasureValuePeer medianPercentileReading
Twelve-month price change, skipping the latest month(30.7%)8.0%24hotter than 24 of 100 peers
Distance from 52-week high(46.1%)(31.4%)31closer to its high than 31 of 100 peers
EBIT to enterprise valuenot computable(1.5%)required accounting or market input is missing
Free cash flow yield(44.5%)(1.0%)13pricier than 87 of 100 peers
Book value to price1.000.2886pricier than 14 of 100 peers
Sales to price0.000.313pricier than 97 of 100 peers
Composite equity issuance, five yearsnot computable20.3%required accounting or market input is missing
Relative strength against the sector, log excess return(0.58)(0.14)24ahead of 24 of 100 peers

Inputs: market equity $59.2M; EBIT -$36.5M; free cash flow -$26.3M; book equity $59.4M; sales $81,000; cash $4.4M[19].

Diagnostics [top]

Diagnostics do not feed the grade.

Piotroski F-score: None of 9, period end 2025-12-31
Return on assets above zero(44.0%)✗ fail[5,7]
Operating cash flow above zero-$25.6M✗ fail[6]
Return on assets improved(9.5 pts)✗ fail[5,7,17,20]
Operating cash flow exceeds net income$6.3M✓ pass[5-6]
Long-term leverage felln/a[1,7,17]
Current ratio improved(23.6 pts)✗ fail[8-9,21-22]
No new shares issuedn/a
Gross margin improvedn/a[2,4,14,23]
Asset turnover improved0.0 pts✓ pass[2,7,14,17]
Cash, filings, liquidity
Cash and equivalents$4.4M[3]
Operating cash flow, four quarters-$27.7M[3,6,24-27]
Months of runway1.9
Late filings, two years0
NT 10-K or NT 10-Q
Days since last periodic filing58
10-Q received Aug 12, 2026
Median daily dollar volume$42,253
63 sessions
Days since newest grade input205

Downloads [top]

Sources [top]

Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.

#ConceptXBRL tagValuePeriod endReceivedFormLinks
1assetsus-gaap:Assets$101.9M2025-12-312026-03-1810-Kfiling · viewer · series
2revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax$81,0002025-12-312026-03-1810-Kfiling · viewer · series
3cashus-gaap:CashAndCashEquivalentsAtCarryingValue$4.4M2026-06-302026-08-1210-Qfiling · viewer · series
4cost of revenueus-gaap:CostOfRevenue$164,0002025-12-312026-03-1810-Kfiling · viewer · series
5net incomeus-gaap:NetIncomeLoss-$31.9M2025-12-312026-03-1810-Kfiling · viewer · series
6operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$25.6M2025-12-312026-03-1810-Kfiling · viewer · series
7assetsus-gaap:Assets$72.6M2024-12-312026-03-1810-Kfiling · viewer · series
8current assetsus-gaap:AssetsCurrent$40.8M2025-12-312026-03-1810-Kfiling · viewer · series
9current liabilitiesus-gaap:LiabilitiesCurrent$24.2M2025-12-312026-03-1810-Kfiling · viewer · series
10retained earningsus-gaap:RetainedEarningsAccumulatedDeficit-$311.7M2025-12-312026-03-1810-Kfiling · viewer · series
11operating incomeus-gaap:OperatingIncomeLoss-$36.5M2025-12-312026-03-1810-Kfiling · viewer · series
12book equityus-gaap:StockholdersEquity$75.4M2025-12-312026-03-1810-Kfiling · viewer · series
13liabilitiesus-gaap:Liabilities$26.5M2025-12-312026-03-1810-Kfiling · viewer · series
14revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax$77,0002024-12-312026-03-1810-Kfiling · viewer · series
15revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax$306,0002023-12-312025-03-1910-Kfiling · viewer · series
16revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax$268,0002022-12-312024-03-2010-Kfiling · viewer · series
17assetsus-gaap:Assets$95.4M2023-12-312025-03-1910-Kfiling · viewer · series
18assetsus-gaap:Assets$116.3M2022-12-312024-03-2010-Kfiling · viewer · series
19shares outstandingdei:EntityCommonStockSharesOutstanding29,293,8312021-08-252021-08-3010-Qfiling · viewer · series
20net incomeus-gaap:NetIncomeLoss-$32.9M2024-12-312026-03-1810-Kfiling · viewer · series
21current assetsus-gaap:AssetsCurrent$47.6M2024-12-312026-03-1810-Kfiling · viewer · series
22current liabilitiesus-gaap:LiabilitiesCurrent$24.8M2024-12-312026-03-1810-Kfiling · viewer · series
23cost of revenueus-gaap:CostOfRevenue$82,0002024-12-312026-03-1810-Kfiling · viewer · series
24operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$15.1M2026-06-302026-08-1210-Qfiling · viewer · series
25operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$8.8M2026-03-312026-05-0610-Qfiling · viewer · series
26operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$19.5M2025-09-302025-11-1310-Qfiling · viewer · series
27operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$13.0M2025-06-302026-08-1210-Qfiling · viewer · series

Limitations [top]

Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.

Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.

Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.

Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.

Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.